Announcements

Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., filed a Form 4 on September 1, 2026, disclosing stock option exercises and common stock sales executed on August 28, 2026, under a pre-established Rule 10b5-1 trading plan.

Rajendra K Talluri, CEO and Director of Kulicke & Soffa Industries Inc, filed a Form 4 on September 1, 2026, reporting the acquisition of 89,697 shares of common stock at no cost under the company's 2021 Omnibus Incentive Plan.

Danny Gilad Allouche, President of the Materials Group at Avery Dennison Corp (NYSE:AVY), filed a Form 4 on September 1, 2026, reporting the acquisition of three equity awards granted on September 1, 2026.

A Form 4 filed on September 1, 2026, discloses that William Raymond Wagner, a director of Avery Dennison Corp (NYSE:AVY), received a supplemental restricted stock unit award in connection with his election as independent Board Chair.

A Form 4 filed with the SEC on September 1, 2026, discloses that John Ternus, CEO and Director of Apple Inc. (NASDAQ:AAPL), was granted 7,690 restricted stock units on that date.

Director Frederick M. Lowery filed a statement of changes in beneficial ownership with the SEC on September 1, 2026, reporting an acquisition of DuPont de Nemours, Inc. common stock dated August 28, 2026.

A Statement of Changes in Beneficial Ownership was filed on September 1, 2026, disclosing that Donald G. Macpherson, a director of DuPont de Nemours, Inc., acquired shares of the company's common stock on August 28, 2026.